Arca biopharma investor alert by the former attorney general of louisiana: kahn swick & foti, llc investigates merger of arca biopharma, inc. - abio

New orleans--(business wire)--former attorney general of louisiana charles c. foti, jr., esq. and the law firm of kahn swick & foti, llc (“ksf”) are investigating the proposed merger of arca biopharma, inc. (the “company”) (nasdaqcm: abio) and oruka therapeutics. upon closing of the proposed transaction, arca shareholders are expected to own approximately 2.38% of the combined company. ksf is seeking to determine whether the merger and the process that led to it are adequate, and whether th.
ABIO Ratings Summary
ABIO Quant Ranking